TBI+BU Conditioning for R/R AML: A 20-Patient Retrospective Clinical Dataset

Wenya Liu's dataset from the Aerospace Center Hospital contains de-identified clinical data for 20 patients with relapsed/refractory acute myeloid leukemia. These patients underwent allogeneic hematopoietic stem cell transplantation with a TBI + BU conditioning regimen between July 2021 and October 2025. The data supports findings in the associated research article and is anonymized per HIPAA Safe Harbor standards.

Use Cases

• Analyzing patient outcomes following TBI+BU conditioning for R/R AML.
• Comparing clinical metrics for a cohort undergoing allogeneic HSCT.
• Supporting retrospective research on transplantation protocols in a single-center setting.

Strengths

• Contains data for 20 patients, providing a defined clinical cohort.
• Data is fully anonymized using the HIPAA Safe Harbor Method.
• Covers a specific time range from July 2021 to October 2025.
• Has ethical approval from the Aerospace Center Hospital Biomedical Ethics Committee.

Limitations

• Column names and data schema are not provided in the metadata.
• The dataset is limited to a single center and a small cohort of 20 patients.
• The row count is not explicitly stated, creating uncertainty about data granularity.

Provenance

Source

Department of Hematology, Aerospace Center Hospital, Beijing, China.

Collection Method

Retrospective clinical data collection.

Time Range

July 2021 to October 2025.

Freshness

Last updated on 2026-03 25.

Geography

Beijing, China.